Answers are grounded in this paper and cite their sources.
Background. Hypothyroidism-related bowel dysfunction may persist despite levothyroxine therapy. Gut-thyroid interactions involving alterations in the intestinal microbiota, visceral hypersensitivity, and neurohumoral regulation may contribute to these manifestations. This study evaluated the effects of 30-day probiotic supplementation on the thyroid hormone profile, bowel function, intestinal microbiota, visceral sensitivity, cortisol, and vasoactive intestinal peptide (VIP) levels in patients with hypothyroidism and constipation or diarrhea. Materials and methods. Eighty-one patients were studied. Of 53 patients with constipation, 28 received Bifidobacterium longum 35624® plus levothyroxine and 25 received levothyroxine alone. Of 28 patients with diarrhea, 14 received a probiotic formulation containing Saccharomyces boulardii plus levothyroxine and 14 received levothyroxine alone. Thyroid-stimulating hormone (TSH), triiodothyronine (T3), thyroxine (T4), VIP, cortisol, visceral sensitivity index (VSI), and intestinal microbiota were assessed. Results. In patients with constipation, B.longum 35624® reduced TSH from 5.79 ± 0.16 to 4.84 ± 0.10 μIU/mL and increased T3 from 1.57 ± 0.08 to 1.96 ± 0.06 nmol/L (p < 0.05). Bowel movement frequency increased from 2.2 ± 0.2 to 3.9 ± 0.2/week, and 71.4 % of patients no longer required regular laxatives. Colonic Bifidobacterium and Lactobacillus counts increased significantly, whereas Bacteroides, Klebsiella, S.aureus, Candida spp., and lactose-negative E.coli decreased. VSI decreased from 59.9 ± 1.6 to 54.1 ± 1.6, cortisol from 328.1 ± 5.9 to 287.3 ± 7.2 nmol/L, while VIP increased from 46.28 ± 1.47 to 53.32 ± 1.40 pg/mL (p < 0.05). In patients with diarrhea, the probiotic formulation reduced TSH from 4.94 ± 0.18 to 4.46 ± 0.13 μIU/mL and increased T4 from 1.38 ± 0.09 to 1.73 ± 0.11 ng/dL (p < 0.05). Loose stool frequency decreased from 3.6 ± 0.3 to 1.5 ± 0.2/day; bloating resolved in 92.9 % and excessive gas in 71.4 % of patients. Small-intestinal Bifidobacterium, Lactobacillus, Bacteroides, and Enterococcus counts decreased significantly. VSI decreased from 62.9 ± 1.9 to 55.0 ± 1.7 and VIP from 151.3 ± 32.2 to 87.6 ± 4.1 pg/mL, whereas cortisol showed a nonsignificant downward trend. Conclusions. Adding probiotics to levothyroxine therapy was associated with favorable changes in thyroid parameters and bowel symptoms, modulation of the intestinal microbiota, and reduced visceral hypersensitivity. VIP responses differed according to the predominant type of bowel dysfunction.
No takes yet. Share an insight, caveat, or question.
Mishchuk et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: